About this event
Join us on Thursday, September 22, at 1 pm ET. Dr. Jeffrey Cummings will discuss drug development and the changing Alzheimer's Disease therapeutic landscape. Dr. Cummings will review in great length the following key items:
Shannon has more than 8 years of experience in the pharmaceutical industry. One of her passions is using her creativity and ingenuity to educate colleagues and the public about the benefits of clinical research.
We are a global, full-service contract research organization (CRO), the only one focused exclusively on central nervous system (CNS) drug development. We are dedicated to bringing new therapies to patients living with mental health, neurological and substance abuse disorders.
Share this event